STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-05-03
Here’s whether Twist Bioscience Corporation Common Stock (TWST) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.26% over 10 days); strong 1-year return of +60.2%; 3-month momentum positive (+29.0%). Currently 8.6% off its 52-week high. Score: +6/7.
TWST is in a confirmed uptrend, trading above both its 50-day ($50.67) and 200-day ($37.46) moving averages. An RSI of 66.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +60.2% compares to +27.9% for SPY (beat the market by 32.3%).
$10,000 invested 1 year ago→ $16,017 today
vs. S&P 500 (SPY) — same period beat market by 32.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($37.46)
✓Above 50-day MA ($50.67)
✓RSI(14) neutral zone (30–70) — currently 66.6
✓Positive return (+60.2%)
✓Within 10% of period high (−8.6%)
Period Range $60.40
$23.30$66.06
RSI (14) 66.6
0 · OversoldOverbought · 100
Key Metrics
Price$60.40
Period Return+60.2%
Period High$66.06
Period Low$23.30
Drawdown−8.6%
MA-50$50.67
MA-200$37.46
RSI (14)66.6
Avg Volume (30d)1.3M
vs. SPYbeat by 31.1%
Return Rank#335 of 1236
Trend Signals
Price is above the 200-day moving average ($37.46)